Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 32.05 0.91 (2.92%) Market Cap: 1.51 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 6.42 GF Score: 44/100

Q2 2021 Mirum Pharmaceuticals Inc Earnings Call Transcript

Aug 05, 2021 / 08:30PM GMT
Release Date Price: $14.54 (-0.62%)
Operator

Hello, everyone, and welcome to the Mirum Pharmaceuticals, Inc. Second Quarter 2021 Business Update. My name is Simona, and I will be your coordinator today. (Operator Instructions)

I will now hand you over to your host, Ian Clements, Chief Financial Officer, to begin. Ian, please go ahead.

Ian Clements
Mirum Pharmaceuticals, Inc. - CFO

Thanks, Simona, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals Second Quarter 2021 Conference Call. I'm joined today by our President and CEO, Chris Peetz; and our Chief Operating Officer, Peter Radovich.

Earlier this afternoon, Mirum issued a news release announcing the company's results for the quarter ended June 30, 2021. Copies of this news release and SEC filings can be found in the Investors section of our website.

Before we begin, I'd like to remind you that during the course of this conference call, we will be making certain forward-looking statements about Mirum, and that program is based on management's current expectations, including statements regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot